Cargando…
Study protocol for a single-centre non-inferior randomised controlled trial on a novel three-dimensional matrix positioning-based cognitive fusion-targeted biopsy and software-based fusion-targeted biopsy for the detection rate of clinically significant prostate cancer in men without a prior biopsy
INTRODUCTION: The classical pathway for diagnosing prostate cancer is systematic 12-core biopsy under the guidance of transrectal ultrasound, which tends to underdiagnose the clinically significant tumour and overdiagnose the insignificant disease. Another pathway named targeted biopsy is using mult...
Autores principales: | He, Biming, Li, Rongbing, Li, Dongyang, Huang, Liqun, Wen, Xiaofei, Yang, Guosheng, Wang, Haifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925935/ https://www.ncbi.nlm.nih.gov/pubmed/33550242 http://dx.doi.org/10.1136/bmjopen-2020-041427 |
Ejemplares similares
-
A Prospective Study and Single-Center Experience: Effectivity of Fusion Prostate Biopsy in Biopsy-Naïve Patients
por: Demirtaş, Türev, et al.
Publicado: (2021) -
A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol
por: Kasivisvanathan, Veeru, et al.
Publicado: (2017) -
A Comparative Study: Has MRI-guided Fusion Prostate Biopsy Changed the Prostate-specific Antigen Gray-zone Range?
por: Sönmez, Gökhan, et al.
Publicado: (2019) -
Software-assisted US/MRI fusion-targeted biopsy for prostate cancer
por: Angileri, Salvatore Alessio, et al.
Publicado: (2020) -
MRI-targeted prostate biopsy: the next step forward!
por: Cata, Emanuel Darius, et al.
Publicado: (2021)